The short answer is this: the form and route of prescribed medical cannabis sit with the prescriber. Smoking is not a substitute for a prescribed route, and a patient should not try to solve a route problem by changing how a medicine is used.
This guide is general UK patient information. It is not medical advice, legal advice, dosing advice, device advice, or a way to decide whether a product or route is suitable for you. If the prescribed route is unclear, difficult, not tolerated, or causing concern, take that back to the prescribing team, pharmacist, or another qualified healthcare professional.
For wider context, MCPH has a patient guide and separate safety pages on medical cannabis side effects and medical cannabis and driving in the UK.
The useful distinction
People often search for “vaping vs smoking” because they are trying to understand a practical difference. In a prescribed medical cannabis context, the more useful distinction is this:
- a prescribed medicine has a form;
- it has instructions and a route decided by the prescriber;
- safety monitoring sits with the clinical team;
- smoking is not a medical workaround.
That is different from non-medical comparison content. This article is not comparing experiences, devices, taste, effects, or strength. It is explaining why the prescribed route matters.
If a patient is prescribed a cannabis-based medicinal product, the prescription and clinical instructions matter. The route is not just a preference box. It can affect side effects, impairment, interactions, monitoring, practical safety, and whether the medicine is being used as prescribed.
Why smoking needs a firm boundary
Smoking should not be presented as a prescribed medical route.
The official UK framework for cannabis-based products for medicinal use was created around medical prescribing, specialist responsibility, and product governance. GOV.UK’s 2018 scheduling circular excludes products intended for smoking from the rescheduled medical definition. That is the safest public boundary for this article: smoking is not the prescribed medical route, and MCPH should not describe it as one.
There is also a patient-safety reason to keep the line clear. If someone is struggling with a prescribed route, the safer action is not to improvise. The safer action is to contact the prescribing team and explain what is happening.
That conversation might include whether the instructions are clear, whether side effects are happening, whether the route is practical, whether other medicines or health conditions change the risk picture, and whether the treatment plan needs review. The article cannot answer those questions for an individual patient.
Where vaping fits in a prescription conversation
The word “vaping” can be confusing because it is used in lifestyle, nicotine, non-medical, and medical contexts. MCPH should avoid blending those worlds together.
In medical cannabis care, the question is not “how do I vape cannabis?” The question is whether a specific prescribed product and route are clinically appropriate for a specific patient, under the prescriber’s instructions.
Patients can raise concerns and preferences. That is not the same as choosing a product or route alone. A patient can say, for example, that they are worried about inhalation, struggling with practical use, concerned about side effects, or unsure whether the route fits their health situation. The prescriber can then decide what is clinically appropriate, including whether any change is needed.
The same boundary applies if a patient wants to discuss oil, flower, extract, or another form. It is reasonable to ask informed questions. It is not safe for a public article to recommend a form, route, dose, product, device, pharmacy, clinic, or strain.
The device barrier is real
For some patients, the difficulty is not whether they accept the prescribed route in principle. It is the practical reality of using it.
Good vaporisers can be expensive. A patient may not know which devices are suitable, how to use them, how to clean them, how to replace parts, how to judge whether the device is working properly, or what to do when the technology makes the prescription feel harder than expected. Replacement parts, cleaning routines, battery life, dexterity, travel, storage and aftercare can all affect whether a prescribed route is realistic in daily life. This can be a real access barrier, especially when a clinic advises a vaporised route but leaves the patient to work out the device side alone.
Clinics should do more than say “use a vaporiser”. They should make sure patients understand the intended route, what sort of device is appropriate, where the clinic’s advice starts and ends, who can answer device questions, and what to do if cost or practical use is a problem. A prescription is more usable when the patient has enough support to follow it safely.
Some well-known devices are made by STORZ & BICKEL. VAPORMED, part of the same group, lists medical-device products such as the VOLCANO MEDIC 2 and MIGHTY+ MEDIC. Patients may also hear names such as Mighty, Crafty, Venty or Volcano in the wider market. The important distinction is that medical-device status belongs to the specific certified Medic models and their intended use, not automatically to every device with a familiar brand name.
This article still cannot recommend a vaporiser. It can say that device suitability, clinic instructions, cost, support, training and practical barriers should be part of the conversation.
Safety questions are part of the route question
Route questions are not only practical. They can be safety questions.
NHS medical cannabis guidance says possible side effects can include dizziness, tiredness, mood or behaviour change, feeling high, hallucinations, and suicidal thoughts, depending on the type of medical cannabis used. NHS guidance also says CBD and THC can affect how other medicines work.
That is why the route, product, other medicines, health history, and daily responsibilities belong in a clinical conversation. NICE guidance expects prescribers to consider possible benefits and harms, dependence risk, mental health, medical history, interactions with other medicines, and ability to drive.
If side effects or impairment are part of the concern, read MCPH’s guide to THC side effects and impairment and the wider guide to medical cannabis and medication interactions. Those pages still come back to the same point: the useful next step is clinical review, not self-directed changes.
What to discuss with the prescriber
A patient does not need to pretend everything is fine if the prescribed route is not working in real life. A clear review is more useful than guessing.
Useful questions might include:
- Can you confirm the intended route and instructions for this prescription?
- What type of vaporiser or medical device is suitable for this prescription?
- Do you provide written device instructions, training, or a support contact?
- What should I do if I cannot afford the device you expect me to use?
- What side effects or warning signs should I report?
- Could this route or product interact with any of my other medicines?
- What should I do if I feel impaired, unusually tired, dizzy, anxious, confused, or not myself?
- Who do I contact if the route is not practical or I cannot follow the instructions safely?
- Are there any mental health, respiratory, cardiovascular, liver, kidney, pregnancy, breastfeeding, immune-system, or medicine-interaction issues that change the review?
- What official advice applies if the medicine could affect driving or safety-critical work?
Those questions keep the decision where it belongs: with the clinical team that can see the prescription, records, medicines, risks, and monitoring plan.
What not to do
Do not treat smoking as a fallback for a prescribed medical route. Do not change the route, dose, product, schedule, or device setup on the basis of a blog post. Do not mix prescribed medical cannabis with non-prescribed cannabis or online cannabinoid products to try to make the prescription work better.
If something feels wrong, frightening, unsafe, or hard to explain, contact the prescribing team, pharmacist, NHS 111, or urgent care as appropriate. If someone is at immediate risk of harm, use emergency help.
For driving, the safest public answer is also bounded. A prescription does not give blanket clearance to drive while impaired. MCPH cannot decide whether you are fit to drive, and a blog article cannot give legal clearance.
FAQ
Is smoking prescribed cannabis allowed?
Do not treat smoking as a prescribed medical route. If you are unsure how a medicine has been prescribed or how it should be used, ask the prescribing team or pharmacist.
Is this guide saying vaping is safe?
No. It explains route boundaries in a prescribed medical context. Whether any route is suitable depends on the patient, product, risks, instructions and clinical monitoring.
Can I change route if the prescribed route is not working for me?
No. Do not change route, dose, product or device setup yourself. Tell the prescribing team what is happening and ask for a review.
Can this article recommend a vaporiser or device?
No. Device and route questions belong with the prescriber, pharmacist or clinic instructions for the specific prescription. The article can still flag that device cost, training and support are legitimate things to raise with the clinic.
Sources
- NHS: Medical cannabis – https://www.nhs.uk/medicines/medical-cannabis/
- NICE NG144 recommendations: Cannabis-based medicinal products – https://www.nice.org.uk/guidance/ng144/chapter/recommendations
- GMC: Information for doctors on cannabis-based products for medicinal use – https://www.gmc-uk.org/professional-standards/learning-materials/information-for-doctors-on-cannabis-based-products-for-medicinal-use
- NHS England: Cannabis-based products for medicinal use – https://www.england.nhs.uk/long-read/cannabis-based-products-for-medicinal-use-cbpms/
- MHRA/GOV.UK: Supply unlicensed medicinal products, also known as specials – https://www.gov.uk/government/publications/supply-unlicensed-medicinal-products-specials
- CQC: Cannabis-based medicinal products: what CQC expects from providers – https://www.cqc.org.uk/guidance-providers/healthcare/cannabis-based-medicinal-products-what-cqc-expects-providers
- GOV.UK: Circular 018/2018: rescheduling of cannabis-based products for medicinal use in humans – https://www.gov.uk/government/publications/circular-0182018-rescheduling-of-cannabis-based-products-for-medicinal-use-in-humans
- VAPORMED: VOLCANO MEDIC 2 – https://www.vapormed.com/en/volcano-medic2
- VAPORMED: MIGHTY+ MEDIC – https://www.vapormed.com/en/mighty-plus-medic
Cover image: TOPIC-023-cover-vaping-prescribed-cannabis-vs-smoking.png.
